Navigation Links
US Peptides Increases Inventory on Sterile Bacteriostatic Water

LARGO, Fla., Jan. 29, 2013 /PRNewswire-iReach/ -- Bacteriostatic water is a sterile water solution used for injection purposes. The difference between Bacteriostatic water and sterile water is that bacteriostatic water contains .09% benzyl alcohol added as a bacteriostatic preservative and sterile water does not.


The bacteriostatic preservative prevents the growth or reproducing of bacteria within the vial.

According to the American Society of Health System Pharmacists (ASHP) the shortage is due to a combination of manufacturing issues as well as an increase in demand of the product.

Supply is estimated to begin to meet demand sometime in February when the manufacturing issues and supply chain is able to catch up to the demand.

US Peptides however was able to secure several hundred vials of sterile bacteriostatic water for injection through vendors that they have fostered long term and trusted relationships. Due to this US Peptides LLC has been able to meet the demand of consumers that are interested in purchasing this product or Sodium Chloride for injection as an option.

US Peptides in the US leader in research peptides, research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.

US Peptides carries a variety of products such as: Melanotan II, CJC-1295, GHRP-6, Sermorelin, IGF1-LR3, GHRP-2, Fragment 176-191, CJC-1295 DAC, Mechano Growth Factor – PEG, Mechano Growth Factor, Hexarelin, Ipamorelin, Melanotan I, Bacteriostatic 0.9% Sodium Chloride and hard to find Bacteriostatic Water.

When visiting the site a purchase of any ten products in any combination will give the buyer an automatic 10% discount on the purchase which will be calculated automatically. is a United States based distributor of the highest grade research peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.

To purchase Bacteriostatic water follow this link-

Media Contact: Don P US Peptides LLC, 727-210-7821,

News distributed by PR Newswire iReach:  

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Physician-Friendly Coding and Compliance Tool Increases Accuracy and Documentation of Patient Charges
2. Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
3. Survey: Hospital Executives Nationwide Facing Operating Room Case Volume Increases, Seeking Greater Efficiency through Healthcare Information Technology (HIT)
4. AMILPAR - Revenues Grow 18% and EBITDA Increases 19% in 1H12
5. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
6. Group Florence Nightingale Increases Radiosurgery Profile with Acquisition of Turkeys First Leksell Gamma Knife Perfexion System
7. Glenmarks Consolidated Revenue Increases by 18.9% to Rs. 12551.9 Mn for Q2 FY12-13
8. Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
9. Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
10. Mesa Labs Increases Quarterly Dividend
11. Service Corporation International Increases Share Repurchase Authorization to $200 Million and Declares Quarterly Cash Dividend
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):